logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
mobile logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
July 22, 2021
Uncategorized

紐約州確診19.5萬例 全州死亡人數破萬

紐約州昨天新增死亡人數671人,同時全州死亡人數破萬,但州長庫默表示,最艱難的時間已經過去,要堅持到底。

截至中午,全美確診558,999例。紐約州確診195,031例,新增6,337例。紐約市確診106,763例,新增3,555例。長島納蘇郡及蘇福郡分別達24,358及21,643例;威徹斯特19,786例。紐約州昨天新增死亡人數671人,總人數升至10,056。但住院率及ICU使用率下降,平均每天增加住院人數在2000人左右。

庫默說,之所以紐約、芝加哥、底特律和華盛頓州是全美重災區,人口密度是一個重要的因素。對於重新開放紐約,需要做到五點:緩解隔離、增加經濟活動、重新定義基本行業、應用更多測試和預防措施,及不增加感染率。而下一步,紐約將參考其他國家的抗疫經驗,針對情況做出詳細計劃,和各系統通力協作,同時需要聯邦政府的幫助。

庫默說,此次疫情不會像有開關一樣,在某個時間戛然而止,短期之內也不會結束。但是,疫情現在已經得到了有效的控制,最艱難的時候已經過去,有特效藥和疫苗才是意義上真正的疫情結束。他表示,根據多個專家的預防,疫苗的研製需要12至18個月的時間,在這段時間之內,能做的就是堅持到底。

今天下午,州長庫默將和多州的州長就疫情和重開經濟進行對話,並將在晚些時候發表聲講話。

分享:

SHARE THIS ARTICLE

by admin
0
0
Previous post 紐約州確診近16萬例 單日死亡數字連續第四天上升
Next post 阿桑奇藏倫敦使館多年爆與女律師偷生2子

即時新聞

賓州警方執行搜捕令時遭槍擊 致三死兩傷

September 18, 2025

賓州警方執行搜捕令時遭槍擊 致三死兩傷

September 18, 2025

川普與英相施凱爾簽署科技協議 加強美英合作

September 18, 2025

擬重新設計堅尼路 紐約市交通局徵詢公眾意見

September 18, 2025

聯大會議和猶太新年將至 紐約市警公佈安全計劃

September 18, 2025
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Advertisement

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

Others

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

SAVE & ACCEPT

Terms and Conditions - Privacy Policy